Elsevier

Neurobiology of Disease

Volume 7, Issue 1, February 2000, Pages 38-53
Neurobiology of Disease

Regular Article
BDNF Blocks Caspase-3 Activation in Neonatal Hypoxia–Ischemia

https://doi.org/10.1006/nbdi.1999.0275Get rights and content

Abstract

Hypoxic–ischemic (H-I) injury to the brain in the perinatal period often leads to significant long-term neurological deficits. In a model of neonatal H-I injury in postnatal day 7 rats, our previous data have shown that cell death with features of apoptosis is prominent between 6 and 24 h after H-I and that neurotrophins, particularly BDNF, can markedly protect against tissue loss. During brain development, caspase-3 is required for normal levels of programmed cell death. Utilizing an antibody specific for the activated form of caspase-3, CM1, we now show that caspase-3 is specifically activated in neuronal cell bodies and their processes beginning at 6 h and peaking 24 h following unilateral carotid ligation and exposure to hypoxia in postnatal day 7 rats. Caspase-3 activation began to occur in cortex at 6 h and in striatum and hippocampus at 12–18 h. Caspase-3 activation was also observed in developing oligodendrocytes. Intracerebroventricular injection of BDNF prior to H-I injury almost completely abolished evidence of H-I-induced caspase-3 activation in vivo. Utilizing a specific molecular marker of an apoptotic pathway, these findings demonstrate that H-I injury to the developing brain is a strong apoptotic stimulus leading to caspase-3 activation, that BDNF can block this process in vivo, and that the ability of BDNF to inhibit caspase activation and subsequent apoptosis likely accounts in large part for its protection against neuronal injury in this model.

References (75)

  • R. Klein et al.

    The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3

    Cell

    (1991)
  • O. Lindvall et al.

    Neurotrophins and brain insults

    Trends Neurosci.

    (1994)
  • X. Liu et al.

    DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis

    Cell

    (1997)
  • P.C. Maisonpierre et al.

    NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression

    Neuron

    (1990)
  • S.J. Martin et al.

    Protease activation during apoptosis: Death by a thousand cuts?

    Cell

    (1995)
  • K. Matsushita et al.

    Alteration of BCL-2 family proteins precedes cytoskeletal proteolysis in the penumbra, but not in infarct centres following focal cerebral ischemia in mice

    Neuroscience

    (1998)
  • H. Mehmet et al.

    Increased apoptosis in the cingulate sulcus of newborn piglets following transient hypoxia–ischaemia is related to the degree of high energy phosphate depletion during the insult

    Neurosci. Lett.

    (1994)
  • J.-P. Merlio et al.

    Increased production of the trkB protein tyrosine kinase receptor after brain insults

    Neuron

    (1993)
  • S. Narumiya et al.

    Enhanced expression of full-length TrkB receptor in young rat brain with hypoxic/ischemic injury

    Brain Res.

    (1998)
  • D.W. Nicholson et al.

    Caspases: Killer proteases

    Trends Biochem. Sci.

    (1997)
  • C. Palmer et al.

    Potential new therapies for perinatal cerebral hypoxia–ischemia

    Clin. Perinatol.

    (1993)
  • S.E. Pfeiffer et al.

    The oligodendrocyte and its many cellular processes

    Trends Cell Biol.

    (1993)
  • L.M. Schwartz et al.

    Cold thoughts of death: The role of ICE proteases in neuronal death

    Trends Neurosci.

    (1996)
  • F.S. Silverstein et al.

    Cytokines and perinatal brain injury

    Neurochem. Int.

    (1997)
  • W.D. Snider

    Functions of the neurotrophins during development: What the knockouts are teaching us

    Cell

    (1994)
  • D. Soppet et al.

    The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor

    Cell

    (1991)
  • S.P. Squinto et al.

    trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor

    Cell

    (1991)
  • Q. Yan et al.

    Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system

    Neuroscience

    (1997)
  • X.F. Zhou et al.

    Distribution of trkB tyrosine kinase immunoreactivity in the rat central nervous system

    Brain Res.

    (1993)
  • L. Aloe

    Intracerebral pretreatment with nerve growth factor prevents irreversible brain lesions in neonatal rats injected with ibotenic acid

    Biotechnology

    (1987)
  • S.A. Back et al.

    Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion

    J. Neurosci.

    (1998)
  • M.H. Cardone et al.

    Regulation of cell death protease caspase-9 by phosphorylation

    Science

    (1998)
  • P.H. Chan et al.

    New insights into the role of oxygen radicals in cerebral ischemia

  • Y. Cheng et al.

    Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury

    J. Clin. Invest.

    (1998)
  • Y. Cheng et al.

    Marked age-dependent neuroprotection by BDNF against neonatal hypoxic-ischemic brain injury

    Ann. Neurol.

    (1997)
  • L. del Peso et al.

    Interleukin-3 induced phosphorylation of BAD through the protein kinase AKT

    Science

    (1997)
  • M. Deshmukh et al.

    Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE-family proteases

    J. Cell Biol.

    (1996)
  • Cited by (265)

    • Water treadmill training protects the integrity of the blood-spinal cord barrier following SCI via the BDNF/TrkB-CREB signalling pathway

      2021, Neurochemistry International
      Citation Excerpt :

      Therefore, much attention has been given to finding a safe and effective rehabilitation method for BSCB and understanding its internal molecular mechanism. It has been reported that brain-derived neurotrophic factor (BDNF) provides anti-inflammatory, and anti-neurotoxic effects, promoting neuronal survival and regeneration (Han et al., 2000; Kitagawa, 2007; Bai et al., 2018). BDNF binds to the receptor TrkB, activating multiple intracellular signalling pathways, one of which includes PI3K/AKT/CREB (Hetman et al., 1999; Klocker et al., 2000; Barnabe-Heider and Miller, 2003).

    • NDRG4 prevents cerebral ischemia/reperfusion injury by inhibiting neuronal apoptosis

      2019, Genes and Diseases
      Citation Excerpt :

      These findings suggest that NDRG4 may serve as a potential target for IR therapy. Several studies have reported that BDNF mitigates severe ischemia-caused brain injury,14 and also inhibits ischemia-induced neuronal apoptosis via regulation of the expression of Bcl-2, Bax, and Caspase-3.31,32 These reports are consistent with our finding that increased NDRG4 levels in IR rats are linked to greater levels of cortical BDNF and the inhibition of neuronal apoptosis.

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed at the Department of Neurology, Washington University School of Medicine, 660 S. Euclid Avenue, Box 8111, St. Louis, MO 63110. Fax: (314) 362-9462. E-mail: [email protected].

    View full text